Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 1

Results: 18

Correction to: Foreword.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 3, doi. 10.1007/s40261-022-01167-1

By:

Mínguez, Beatriz;
Lledó-Navarro, José Luis

Publication type:

Article

Management of Pharmacologic Adverse Effects in Advanced Liver Disease.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 33, doi. 10.1007/s40261-022-01150-w

By:

García-Cortés, Miren;
García-García, Alberto

Publication type:

Article

Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications).

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 15, doi. 10.1007/s40261-022-01149-3

By:

Téllez, Luis;
Guerrero, Antonio

Publication type:

Article

Foreword.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 1, doi. 10.1007/s40261-022-01148-4

By:

Mínguez, Beatriz;
Lledó-Navarro, José Luis

Publication type:

Article

Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 25, doi. 10.1007/s40261-022-01147-5

By:

Baiges, Anna;
Hernández-Gea, Virginia

Publication type:

Article

Management of Alcohol-Related Liver Disease and Its Complications.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 47, doi. 10.1007/s40261-022-01143-9

By:

Cabezas, Joaquín

Publication type:

Article

Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 5, doi. 10.1007/s40261-022-01146-6

By:

García-Martínez, Rita;
Diaz-Ruiz, Raquel;
Poncela, Marta

Publication type:

Article

General Overview About the Current Management of Nonalcoholic Fatty Liver Disease.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 39, doi. 10.1007/s40261-022-01142-w

By:

Ampuero, Javier

Publication type:

Article

Nutrition and Chronic Liver Disease.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 55, doi. 10.1007/s40261-022-01141-x

By:

Aller de la Fuente, Rocío

Publication type:

Article

Application of Multicriteria Decision Analysis to Determine the Value of Prophylaxis Relative to On-Demand Treatment in Hemophilia A and Emicizumab versus Replacement Therapy in the Greek Healthcare Setting.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 75, doi. 10.1007/s40261-021-01108-4

By:

Gourzoulidis, George;
Stefanou, Garyfallia;
Economou, Marina;
Vakalopoulou, Sofia;
Filippidis, George;
Soultatis, George;
Kontos, Dimitrios;
Tzima, Sotiria;
Ntemousis, Fotis;
Fassa, Angeliki;
Kourlaba, Georgia

Publication type:

Article

The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [<sup>14</sup>C]-BI 425809 in Healthy Males.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 87, doi. 10.1007/s40261-021-01111-9

By:

Burkard, Ute;
Desch, Michael;
Shatillo, Yury;
Wunderlich, Glen;
Mack, Salome Rebecca;
Schlecker, Christina;
Teitelbaum, Aaron M.;
Liu, Pingrong;
Chan, Tom S.

Publication type:

Article

Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 17, doi. 10.1007/s40261-021-01110-w

By:

Wang, Feiyu;
Mao, Yinjun;
Wang, Hang;
Liu, Yiwei;
Huang, Pinfang

Publication type:

Article

Safety and Efficacy of the FLECTOR (Diclofenac Epolamine) Topical System in Children with Minor Soft Tissue Injuries: A Phase IV Non-randomized Clinical Trial.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 43, doi. 10.1007/s40261-021-01101-x

By:

Jones, Christopher A.;
Hoehler, Fred K.;
Frangione, Valeria;
Ledesma, Gilbert;
Wisman Jr, Paul P.;
Jones, Clarence

Publication type:

Article

Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 65, doi. 10.1007/s40261-021-01104-8

By:

Lehert, Philippe

Publication type:

Article

Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 53, doi. 10.1007/s40261-021-01103-9

By:

Chu, Nan-nan;
Zhang, Lin;
Wang, Jiakun;
Gu, Xianghong;
Ding, Ying;
Huang, Kai;
Que, Lin-Ling;
He, Qing

Publication type:

Article

Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 29, doi. 10.1007/s40261-021-01100-y

By:

Weisel, Katja;
Martin, Thomas;
Krishnan, Amrita;
Jagannath, Sundar;
Londhe, Anil;
Nair, Sandhya;
Diels, Joris;
Vogel, Martin;
Schecter, Jordan M.;
Banerjee, Arnob;
Berdeja, Jesus G.;
Nesheiwat, Tonia;
Garrett, Ashraf;
Qi, Keqin;
Valluri, Satish;
Usmani, Saad Z.;
Yong, Kwee

Publication type:

Article

Correction to: Filgotinib in Rheumatoid Arthritis: A Profile of Its Use.

Published in:

2022

By:

Kim, Esther S.;
Keam, Susan J.

Publication type:

Correction Notice

Comparing Sacubitril/Valsartan Against Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure: A Systematic Review and Network Meta-analysis.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 1, p. 1, doi. 10.1007/s40261-021-01098-3

By:

Teo, Yao Neng;
Teo, Yao Hao;
Syn, Nicholas L.;
Yoong, Celine Shuen Yin;
Cheong, Alex Jia Yang;
Wee, Caitlin Fern;
Lim, Yoke-Ching;
Lee, Chi-Hang;
Yeo, Tiong-Cheng;
Chai, Ping;
Wong, Raymond C. C.;
Lin, Weiqin;
Sia, Ching-Hui

Publication type:

Article